82
11. Burbach J.P.H., Prinz J.L.M., Lebouille, Verhoef J., WitterA. Sensitive and rapid
amino acid analysis of peptide hydrolysates by high performance liquid
chromatography of o-phtaldialdehtde derivates. J. Chromatogr., v. 237, p. 339-343
(1982)
12. Capony, F., Rougeot, C., Montcourrier, P., Cavailles, V., Salazar, G., Rochefort, H.
Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human
mammary cancer cells. Cancer Research, v. 49, p. 3904-3909 (1989)
13. Canduri, F.; Teodoro, L.G.V.L.; Fadel, V.; Lorenzi, C.C.B.; Hial, V.; Gomes, R.A.S.;
Ruggiero Neto, J.; Azevedo Jr, W.F. Structure of human uropepsin at 2,45 Å
resolution. Biological Crystallography, v. D57, p. 1-8 (2001)
14. Canduri, F.; Teodoro, L.G.V.L.; Lorenzi, C.C.B.; Gomes, R.A.S.; Fontes, M.R.M.;
Arni, R.K.; Azevedo Jr, W.F. Crystalization, preliminary X-ray analysis and Patterson
search of a new aspartic protease isolated from human urine. Biochemistry and
Molecular Biology International, v. 46, p. 355-363 (1998)
15. Chao, J.; Chao, L. Kallicrein-kinin in stroke, cardiovascular and renal disease. The
Physiological Society, v. 90, p. 291-298 (2004)
16. Chao, J.; Stallone, J.N.; Liang, Y.; Chen, L.;Wang D.; Chao, L. Kallistatin is a potent
new vasodilator. Journal of Clinical Investigation, v.100, p. 11-17 (1997)
17. Chao, J.; Chai, K.X.; Chao L. Tissue kallikrein inhibitors in mammals.
Immunopharmacology, v. 32, p. 67-72 (1996)
18. Chao, J.L.; Schmaier, A.; Chen, L.M.; Yang, Z.R.; Chao, L. Kallistatin, a novel
human tissue kallikrein inhibitor: Levels in body fluids, blood cells, and tissues in
health and disease. Journal of Clinical Medicine, v. 127, p. 612-620 (1996)
19. Chen, V.C.; Chao, L.; Pimenta, D.C.; Bledsoe, G.; Juliano, L.; Chao, J. Identification
of a major heparin-binding site in kallistatin. The Journal of Biological Chemistry,
v. 276, p. 1276-1284 (2000)
20. Chen, L-M.; Song, Q.; Chao, L.; Chao, J. Cellular localization of tissue kallikrein and
kallistatin mRNAs in human kidney. Kidney International, v. 48, p. 690-697 (1995)
21. Cooper, J.B. Aspartic Proteinases in Disease: A Structural Perspective. Current Drug
Targets, v. 3, p. 155-173 (2002)
22. Cooper, J.B., Khan, G., Taylor, G., Tickle, I.J., Blundell, T.L. X-ray analyses of
aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of